Evaluation and Modeling with the Therapeutic Effects Group
Members
Stagiaire
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87

Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18

Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83

Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99

Doctorante
autre
Tel: 04 72 44 81 42

Praticien hospitalier
HCL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier émérite
UCBL

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01

Post-doc
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 361 to 390 publications on 626 in total
Introduction of a paediatric anaesthesia comic information leaflet reduced preoperative anxiety in children
British Journal of Anaesthesia . 117 : 95-102
DOI: 10.1093/bja/aew154
Journal article
see the publicationAccurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software
Therapeutic Drug Monitoring . 38 : 332-342
Journal article
see the publicationShould busulfan therapeutic range be narrowed in pediatrics? Experience from a large cohort of hematopoietic stem cell transplant children
Bone Marrow Transplantation . 51 : 72-78
DOI: 10.1038/bmt.2015.218
Journal article
see the publicationMathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study
Journal of Theoretical Biology . 399 : 43-52
Journal article
see the publicationAntihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
Cochrane database of systematic reviews (Online) . 3 : CD011745
Journal article
see the publicationOne-step partial or complete caries removal and bonding with antibacterial or traditional self-etch adhesives: study protocol for a randomized controlled trial
Trials . 17 ( 1 ) : 404
Journal article
see the publicationImpact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
PLoS ONE . 11 : e0145958
Journal article
see the publicationPharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections
Antimicrobial Agents and Chemotherapy . 60 ( 5 ) : pp. 3148-3151
DOI: 10.1128/AAC.02597-15
Journal article
see the publicationComparison of the static in vivo approach to a physiologically based pharmacokinetic approach for metabolic drug-drug interactions prediction
International Journal of Pharmacokinetics . : 1-10
Journal article
see the publicationMetformin as firstline treatment for type 2 diabetes: are we sure?
BMJ-BRITISH MEDICAL JOURNAL . 352 : h6748
DOI: 10.1136/bmj.h6748
Journal article
see the publicationIs the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?
Journal of Cystic Fibrosis . 15 ( 1 ) : 10 - 20
Journal article
see the publicationBaclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation
European Neuropsychopharmacology . 25 : 1631-1636
Journal article
see the publicationDes ruptures de stock aux conséquences parfois graves : l’exemple de la phénytoïne, à propos de 7 cas
Thérapie . 70 ( 4 ) : 377-380
Journal article
see the publicationAttitudes of community pharmacists to off-label prescribing of baclofen in Northern France
International Journal of Clinical Pharmacy . 37 ( 2 ) : 296-299
Journal article
see the publicationTemporary Recommendation for Use on Off-label Baclofen: Viewpoint of Prescribers of the CAMTEA System
Thérapie . 70 ( 2 ) : 235-238
Journal article
see the publicationBullous pemphigoid induced by vildagliptin: a report of three cases
Fundamental & Clinical Pharmacology . 29 ( 1 ) : 112-114
DOI: 10.1111/fcp.12083
Journal article
see the publicationSafety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study
International Clinical Psychopharmacology . 30 ( 1 ) : 49-53
Journal article
see the publication[Drug Shortage May Have Serious Outcome: the French Exemple of Phenytoine].
Thérapie . 70 ( 4 ) : 377-80
Journal article
see the publicationIncorrect evaluation of the frequency of malnutrition and of its screening in hospitalized children by health care professionals
Journal of Evaluation in Clinical Practice . 21 ( 5 ) : 958-62
DOI: 10.1111/jep.12412
Journal article
see the publicationChoisir la forme pharmaceutique orale la plus adaptée à l'enfant
Archives de Pédiatrie . 22 : 877-85
Journal article
see the publicationRisk of medication error administering ciprofloxacin oral suspension in children
European journal of clinical pharmacology . 71 : 769-70
Journal article
see the publicationOverview of pediatric organ transplantation: current opinion and future perspectives on immunosuppression
Current Opinion in Organ Transplantation . 20 : 527-35
Journal article
see the publicationGastrointestinal tolerance of erythritol-containing beverage in young children: a double-blind, randomised controlled trial
European Journal of Clinical Nutrition . 69 ( 6 ) : 746-751
DOI: 10.1038/ejcn.2015.4
Journal article
see the publicationIs HbA a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
Diabetes & Metabolism . 41 : 195-201
Journal article
see the publicationA Bayesian Model to Describe Factors Influencing Trough Levels of Vancomycin in Hemodialysis Patients
Nephron Physiology . 131 ( 2 ) : 131-7
DOI: 10.1159/000439230
Journal article
see the publicationAre ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study
Fundamental & Clinical Pharmacology . 29 ( 6 ) : 615-624
DOI: 10.1111/fcp.12156
Journal article
see the publicationŒdèmes des membres inférieurs au cours d’un traitement par valpromide : cas clinique et revue de la littérature
La Revue de Médecine Interne . 36 ( 10 ) : 698-700
Journal article
see the publicationQuantitative Methods for Prediction of the Effect of Cytochrome P450 Gene Polymorphisms on Substrate Drug Exposure
Clinical Pharmacokinetics . 54 ( 3 ) : 319-320
Journal article
see the publicationCan we identify response markers to antihypertensive drugs? First results from the Ideal Trial
Journal of human hypertension . 29 ( 1 ) : 22-27
DOI: 10.1038/jhh.2014.29
Journal article
see the publicationUnlicensed and off-label drug use: a prospective study in French NICU
Acta Paediatrica . 104 : e228-31
DOI: 10.1111/apa.12924
Journal article
see the publication
You also, comment on this article